Executive Director, Regulatory & Clinical Development Advisor
Eli Lilly and Company
Boston, MA, United States
Ann Hickox, PhD is Executive Director, Regulatory & Clinical Development Advisor at Eli Lilly and Company. Her current role involves developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with hearing loss. She received a PhD from Massachusetts Institute of Technology and has 15 years of research experience in auditory neuroscience. She has presented her work at numerous national and international conferences.
Disclosure information not submitted.
Rationale and Trial Design for an AK-antiVEGF Gene Therapy Trial for Vestibular Schwannoma
Monday, October 13, 2025
9:48 AM - 9:54 AM EDT